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Abstract
Background: Umbilical metastasis is one of the main characteristic signs of extensive neoplastic
disease and is universally referred to as Sister Mary Joseph's nodule.
Case presentation: A 59-years-old Caucasian female underwent liver transplant for end stage
liver disease due to hepatitis C with whole graft from cadaveric donor in 2003. After
transplantation the patient developed multiple subcutaneous nodules in the umbilical region and
bilateral inguinal lymphadenopathy. The excision biopsy of the umbilical mass showed the features
of a poorly differentiated papillary serous cystadenocarcinoma. Computed tomographic scan and
transvaginal ultrasonography were unable to demonstrate any primary lesion. Chemotherapy was
start and the dosage of the immunosuppressive drugs was reduced. To date the patient is doing
well and liver function is normal.
Conclusions: The umbilical metastasis can arise from many sites. In some cases, primary tumor
may be not identified; nonetheless chemotherapy must be administrated based on patient's history,
anatomical and histological findings.
Background
Metastases to the umbilicus are universally referred to as
Sister Joseph's (or Sister Mary Joseph's) nodule. Etiology
is related to the presence of primary malignant disease in
the abdominal cavity or occasionally in the chest and/or
breast [1-5]. Historically, Sister Mary Joseph (1856–1939)
was a surgical assistant under the guidance of Dr. William
Mayo. She was the first one to note the connection
between the umbilical nodule and intra-abdominal can-
cer. The first case reporting the presence of Sister Mary
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Joseph's nodule was in 1864 by Storer, however; Hamil-
ton Bailey was the first one to use the term "Sister Mary
Joseph's nodule.
Although skin metastasis is rare and range between 5%
and 9%, it is estimated that 1% to 3% of abdomino-pelvic
tumors metastasize to the umbilicus [2,3,5]. The most
common primary neoplasm is adenocarcinoma (75%),
more rarely squamous cell carcinoma followed by undif-
ferentiated tumors or carcinoid can metastasize to umbili-
cus. In men, gastrointestinal tract (55%) is the most
common location of the primary neoplasm that metasta-
sizes to the umbilicus, followed by stomach, colon, rec-
tum, small bowel, and pancreas in a decreasing order [1-
5]. In women, on the other hand, gynecological neo-
plasms particularly ovarian cancer is the most common
primary site, of which serous papillary cystadenocarci-
noma (34%) is the most frequent. Further, endometrial
carcinoma, cervix, vagina and vulva may also be responsi-
ble for the metastasis to the umbilicus. In addition to
these the literature reports other but rare sites that could
form potential grounds for metastasis to the umbilicus,
namely gallbladder, liver, breast, lung, prostate, penis,
peritoneum, lymphoma, bladder and kidney. In about
11% of the umbilical metastasis, the origin of the metas-
tasis is unknown [4,5]. Upon recognition of the positive
nodules in the umbilicus, physician must consider other
potential sources such as endometriosis, melanocytic
nevi, fibroma, epithelial inclusion cysts, seborrheic kera-
tosis, pilonidal sinus, keloid, foreign body granulomas,
myxoma, omphalitis, abscesses, umbilical hernia and of
course primary malignant umbilical tumor (melanoma,
squamous and basal cell carcinoma, sarcoma and adeno-
carcinoma) [6]. In many instances, Sister Joseph's nodule
is the first and often the only indication of an underlying
or occult cancer and/or may indicate recurrence of previ-
ously treated malignancy. The presence of umbilical
metastasis usually suggests already advanced metastatic
process characterized by poor prognosis [4,5]. Therefore,
a biopsy of umbilical nodule is recommended which is
safe and easy. Obtaining histological description can fur-
ther direct the clinician to dictate a prompt treatment. In
the case of recurrence of the neoplasm, fine needle aspira-
tion cytology may be sufficient to provide definite diagno-
sis; however, sometimes clinical, cytological, histological,
radiological and/or surgical investigations may not be suf-
ficient to identify primary site of the metastasis [7].
Serous papillary cystadenocarcinoma has been docu-
mented previously as a cancer responsible for Sister
Joseph's nodule because of the metastasis to the regional
lymph nodes [6-9]. Herein, we report, to the best of our
knowledge, the first case of Sister Joseph's nodule in a
patient after liver transplantation complicated by serous
papillary cystadenocarcinoma. In addition, we review the
potential routes by which tumor spread may have
occurred and the prognostic significance associated with
umbilicus metastasis.
Case presentation
A 59-year-old Caucasian woman was admitted to our hos-
pital for progressively enlarging but painless mass in the
region of the umbilicus. The umbilical mass of approxi-
mately 5 cm in diameter and has developed two months
after liver transplantation. The nodule was firm with irreg-
ular borders, wine-red shade and fixed to the surrounding
tissues. The overlying skin was not ulcerated. She never
smoked, consumed alcohol or used oral contraceptive
pills. The gynecological history was unremarkable. The
patient underwent a liver transplantation for end stage
liver disease (ESLD) secondary to hepatitis C in mid of
2003. Prior to the transplant, her serum alpha-fetoprotein
(alpha-FP) and CEA concentration were measured and
both were within normal limits. The transplant procedure
and immediate post-transplant period were unremarka-
ble. The post-transplant immunosuppressive regimen
consisted of Tacrolimus (6 mg/day) and steroids (pred-
nisone 10 mg/day). Two months after transplantation,
during routine follow-up, physical examination revealed
multiple subcutaneous satellite nodules in close proxim-
ity to the umbilical region and lower abdominal wall.
There was bilateral inguinal lymphadenopathy. A plain
anterior/posterior chest x-ray was normal. Ultrasound of
the abdominal cavity showed a 4 × 4 cm mass below the
umbilicus and additional smaller nodules confined to the
lower abdominal wall. Paraaortic lymph nodes were not
identified. The echogenicity of the mass consisted of alter-
native hyper- and hypoechoic with poorly defined edges.
However, the general condition of the patient was good
and the laboratory test showed: hemoglobin level 9.6 g/
dl, total bilirubin 0.6 mg/dl, conjugated bilirubin 0.1 mg/
dl, Alkaline Phosphates 273 U/l, GGT 40 U/L, AST 36 U/
L, and ALT 56 U/L. There was serological evidence of past
hepatitis C virus infection. The biopsy of the umbilical
mass showed features characteristic for a poorly differen-
tiated serous papillary cystadenocarcinoma. An extended
resection of the umbilical and paraumbilical metastasis
was performed. In addition, extensive investigation to
detect the primary neoplastic origin was initiated. Tumor
marker evaluation consisted of: CEA 0.22 [normal 0–3.7
ng/ml], alpha feto protein 1.49 (normal: 0.8–9.4 UI/ml),
CA125 27.73 (normal: 0–30 UI/ml), CA 19.9 was 8.61
(normal: 0–36.2 UI/ml), CA 15.3 was 22.48 (normal: 0–
35 UI/ml). Multiple tumor marker measurements were
obtained and each time similar results were reported. A
computed tomographic (CT) scan was unable to demon-
strate any lesion that could be considered a primary
source of the metastasis to the umbilicus. Trans-vaginal
ultrasonography showed a normal uterus and ovaries;
ultrasonographic examination of thyroid and breast didWorld Journal of Surgical Oncology 2005, 3:4 http://www.wjso.com/content/3/1/4
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not show any pathological changes as well. In spite of
laborious efforts, the tumor's primary site was not found
at that time. However, considering the histological results,
the umbilicus metastasis could be attributed almost
entirely to the ovarian cancer stage 4, since the main pri-
mary site in females are the ovaries. In order to prevent
Preoperative Sister Mary Joseph's nodule ultrasonography: 4 × 4 cm mass confined below the umbilicus (arrows) Figure 1
Preoperative Sister Mary Joseph's nodule ultrasonography: 4 × 4 cm mass confined below the umbilicus (arrows). The main 
lesion is partly hyperechoic and partly hypoechoic with a poorly defined edge.World Journal of Surgical Oncology 2005, 3:4 http://www.wjso.com/content/3/1/4
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further tumor extension and expansion, tacrolimus was
reduced from 6 mg/day to 1.5 mg/day. In addition, chem-
otherapy with Taxol was initiated (50 mg/m2 I.V) once a
week for 16 weeks. To date, after 6 months of follow-up,
the patient is doing well, the liver function is normal and
tacrolimus serum level is 1 ng/ml. A recent whole body
CT-scan showed regression of iliac and inguinal lymph
nodes involvement.
Discussion
Metastases may appear virtually anywhere in the body;
however, certain sites are more common then others and
umbilical metastasis are unusual sites [9,10]. In majority
of cases, the metastatic lesions accompany the symptoms
and signs of the primary tumor; however, it can be the first
and often the only sign of a carcinoma, although this hap-
pens rarely [10]. A variation in vascularity and embryolog-
ical development makes the umbilicus easy target for
Intraoperative specimen of the umbilical region: Sister Mary Joseph's nodule and umbilicus Figure 2
Intraoperative specimen of the umbilical region: Sister Mary Joseph's nodule and umbilicus.World Journal of Surgical Oncology 2005, 3:4 http://www.wjso.com/content/3/1/4
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metastasis from an intra-abdominal tumor. In fact, during
fetal development, the ductus venous (ductus venous
Arantii) connects the umbilical portion of the left branch
of the portal vein to the inferior vena cava, thus shunting
oxygenated umbilical cord blood away form the liver.
After birth the duct obliterates and persists as ligamentum
venosum or Arantius' ligament. Because of its functional
role, it is commonly believed that the ligament runs from
the left branch of the portal vein to the vena cava itself.
However, attention to anatomical detail demonstrates
that the fibers of the ligament insert either on the left
hepatic vein or at the junction between the left hepatic
and the middle hepatic vein [1,11]. We know that in cir-
rhotic patients, the umbilical vein remains open due to
portal hypertension.
There are numerous potential routes by which a carci-
noma can metastasize to the umbilicus in a liver trans-
plant recipient. Malignant carcinomatous cells in the
portal venous system may reach the umbilicus by way of
a patent umbilical vein [12-15]. This would be more likely
to occur in the presence of portal hypertension and the
resulting portal-systemic shunting of blood [16]. Since
our patient received liver transplant for cirrhosis second-
ary to hepatitis C virus infection accompanied by portal
hypertension, this could be a possible mode of spread of
papillary serous cystadenocarcinoma in our patient. In
addition, presence of severe esophageal varicies and large
umbilical vein that was viewed by angiography examina-
tion before the liver transplantation could have contrib-
uted to the spread of tumor. Therefore, in this case,
malignant cells could have reached the umbilicus via the
umbilical vein. In addition, a pelvic carcinoma of
unknown origin may spread via lymph nodes to the
umbilical region [9,17,18]. Furthermore, dermal lym-
phatics are a potential route of spread to the umbilicus
and should be considered, since the umbilicus can be
reached by retrograde lymphatic flow [4]. Nevertheless,
the spread of malignant cells could have occurred via
embolization thru the arterial blood supply to the umbili-
cus. Furthermore, direct implantation of tumor cells may
have occurred via direct extension of the neoplasm from
the anterior peritoneal surface or via redistribution of the
peritoneal fluid flow [19,20]. Finally, cutaneous metasta-
sis to the anterior abdominal wall, may perhaps cause
malignant cells to spread in a retrograde direction, namely
from the metastatic lesions along the subcutaneous lym-
phatic vessels to the umbilicus. It is known that the immu-
nosuppression promotes tumor spreading and potentates
its expansion, thus immunosuppressive regimen plays a
crucial role in the tumor expansion and metastasis.
Umbilical metastasis is one of many characteristic signs of
extensive neoplastic disease. It suggests advanced distant
metastasis and is associated with poor prognosis; mean
survival is approximately 10–12 months, although long-
term survival has been reported, but only in the presence
of solitary metastatic umbilicus nodule [5].
Conclusions
Presence of umbilical nodule or nodules requires exten-
sive, meticulous and laborious evaluations since the dif-
ferential diagnosis for umbilical nodule are many. In our
case although, the primary tumor was not found, we
treated it as ovarian tumor considering the histological
findings and the iliac-inguinal nodes involvement.
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